StonvexLoading…
StonvexStonvexStonvexCore line items from AQMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-18.78M | $-8.68M | $-23.85M | $-17.16M |
Net Income | $-18.21M | $-8.31M | $-24.55M | $-17.11M |
EPS (Diluted) | $-17.35 | $-10.27 | $-38.25 | $-27.73 |
Total Assets | $10.50M | $18.07M | $26.36M | $28.48M |
Total Liabilities | $3.98M | $8.53M | $10.12M | $7.58M |
Cash & Equivalents | $3.59M | $1.59M | $4.08M | $2.95M |
Free Cash Flow OCF − CapEx | $-8.07M | $-3.04M | $-21.55M | $-19.09M |
Shares Outstanding | 1.85M | 8.36M | 773.08K | 6.83M |